The levels of PCSK6 are not associated with worse respiratory outcomes in patients with mixed fibrotic interstitial lung disease.

Topline results from the phase 3 REVITALYZ study show sodium oxybate extended release improves daytime sleepiness in idiopathic hypersomnia.

Regulatory mechanisms mediated by non-coding RNAs provide valuable insights into the pathogenesis of idiopathic pulmonary fibrosis.

IL-4Rα inhibition with rademikibart does not lead to hypereosinophilia in adults with asthma, according to an exploratory analysis.

Left ventricular hemodynamic patterns derived from diastolic deceleration impulse hemodynamic force ratio are an independent prognostic predictor in PH.

The 300 IR house dust mite SLIT tablet may improve allergic rhinitis symptoms in children with HDM allergic rhinitis during active disease periods.

The current guideline of 150 minutes/week moderate-to-vigorous physical activity reduces CVD risk about 8 to 9 percent.

Many older adults see cannabis as a more effective or nonpharmaceutical option to manage sleep, pain, or mental health.

The FDA has granted Priority Review to Bayer’s sNDA for sevabertinib as a first-line treatment for adult patients with HER2-mutant locally advanced or metastatic NSCLC.

Many pMDIs prescribed for severe asthma could be replaced with sustainable alternatives without compromising high patient adherence rates.

A parental support package can significantly mitigate postpartum burnout among childbearing physicians in training.

Dupilumab and upadacitinib were associated with greater improvements in AD severity when compared with methotrexate, cyclosporine, and phototherapy.